Dimensional Fund Advisors
PLRX icon

Dimensional Fund Advisors’s Pliant Therapeutics PLRX Stock Holding History

Dimensional Fund Advisors’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125K Sell
99,773
-21,983
-18% -$27.8K ﹤0.01% 3100
2025
Q4 		$149K Sell
121,756
-29,917
-20% -$44.9K ﹤0.01% 3115
2025
Q3 		$225K Sell
151,673
-164,214
-52% -$251K ﹤0.01% 3106
2025
Q2 		$367K Sell
315,887
-195,831
-38% -$277K ﹤0.01% 3045
2025
Q1 		$691K Sell
511,718
-35,579
-7% -$216K ﹤0.01% 2951
2024
Q4 		$7.21M Buy
547,297
+91,131
+20% +$1.24M ﹤0.01% 2428
2024
Q3 		$5.11M Buy
456,166
+150,844
+49% +$1.89M ﹤0.01% 2513
2024
Q2 		$3.28M Buy
305,322
+5,152
+2% +$66.4K ﹤0.01% 2625
2024
Q1 		$4.47M Buy
300,170
+146,098
+95% +$2.41M ﹤0.01% 2579
2023
Q4 		$2.79M Buy
154,072
+97,420
+172% +$1.48M ﹤0.01% 2718
2023
Q3 		$982K Sell
56,652
-74,059
-57% -$1.28M ﹤0.01% 2932
2023
Q2 		$2.37M Sell
130,711
-81,745
-38% -$1.94M ﹤0.01% 2728
2023
Q1 		$5.65M Buy
212,456
+68,489
+48% +$1.95M ﹤0.01% 2446
2022
Q4 		$2.78K Buy
143,967
+124,106
+625% +$2.59M ﹤0.01% 2628
2022
Q3 		$415K Buy
19,861
+5,154
+35% +$98.6K ﹤0.01% 3083
2022
Q2 		$118K Buy
14,707
+1,224
+9% +$7.84K ﹤0.01% 3312
2022
Q1 		$95K Buy
+13,483
New +$138K ﹤0.01% 3399

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Dimensional Fund Advisors's PLRX Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Pliant Therapeutics (PLRX) stake by 18% in Q1 2026, selling an estimated $27.8K and leaving 99,773 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #3100.

Dimensional Fund Advisors first reported a position in PLRX in Q1 2022 and has held it in 17 quarters since. The position peaked at $7.21M in Q4 2024. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Dimensional Fund Advisors held 99,773 shares of Pliant Therapeutics worth $125K as of Q1 2026.
  • Dimensional Fund Advisors sold 21,983 Pliant Therapeutics shares in Q1 2026, an estimated $27.8K.
  • Pliant Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3100 holding.
  • Dimensional Fund Advisors first reported a position in Pliant Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Dimensional Fund Advisors's Pliant Therapeutics position peaked at $7.21M in Q4 2024.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.